The study is a single, cross-sectional cognitive interview of FuRST 2.0, functional rating scale, administered to Huntington’s Disease Gene Expansion Carriers (HDGECs). The scale will be tested as a patient reported outcome (PRO) in that the information will come directly from the participant through self-report.
FuRST 2.0: Cognitive Pre-testing for a New Functional Rating Scale for Use in Huntington’s Disease – Round 2
The purpose is to identify real or potential comprehension or usage problems with scale items, response options, instructions and disclaimer statement, which are all components of the FuRST 2.0 scale. Through a structured cognitive interview with the participants, followed by qualitative analysis, the final phrasing of the individual scale items, response options, instructions and disclaimer statement for the scale will be generated. Depending on the results of this study, additional rounds of cognitive pre-testing may be required.
Canadian Locations and Contact Information:
Location: Centre for Movement and Disorders at 1 Valleybrook Drive, Suite 400, Toronto, ON M3B 2S7
Coordinator: Teena Kailasanathan
Phone: 416-847-7084, ext. 235
Exclusion Criteria (eligibility that would exclude you from this study)
- Significant cognitive or any other impairment sufficient to interfere with study associated tasks as judged by the site PI or the site PI’s designee
ClinicalTrials.gov A service of the U.S. National Institutes of Health
This study is no longer recruiting participants (see Contacts and Locations).
For more detailed information on this study and others and for the most recent updates, please go to clinicaltrials.gov ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.